Prosthetic heart valve thrombosis as a source of coronary embolism: a novel strategy in the management of acute coronary syndrome (the Troia-core trial)

S. Karakoyun, O. M. Gursoy, M. Kalcik, H. Kaya, T. Gokdeniz, S. Gunduz, M. Yesin, M. Yildiz, N. E. Duran, M. Ozkan
2013 European Heart Journal  
Conclusions: This meta-analysis did not show any differences in long-term mortality rates, thromboembolic events, or hemorrhage between BP and MP patients after 20 years of follow-up. However, MP was associated with lower risks of all other outcomes, except paravalvular leak. P2133 | BEDSIDE Prosthetic heart valve thrombosis as a source of coronary embolism: a novel strategy in the management of acute coronary syndrome (the Troia-core trial)
doi:10.1093/eurheartj/eht308.p2133 fatcat:qubecdetynhjlgggn6bwqktfne